Az oldal megfelelő megjelenítéséhez engedélyezze böngészőjében a JavaScript használatát!

You are here

Juhászné Wachal Zita

Juhászné Wachal Zita

Name: Juhászné Wachal Zita

Publication list

printer-friendly version

Export to MTMT compatible RIS file
Upload publications
Request certified publication list

Uploaded publications:

4

Publications in DEA:

4

OA:

3

Date range:

2013-2023

2023

Blaga, Z., Czine, P., Takács, B., Szilágyi, A., Szekeres, R., Wachal, Z., Hegedűs, C., Buchholcz, G., Varga, B., Priksz, D., Bombicz, M., Szabó, A., Kiss, R., Gesztelyi, R., Romanescu, D., Szabó, Z., Szűcs, M., Balogh, P., Szilvássy, Z., Juhász, B.: Examination of Preferences for COVID-19 Vaccines in Hungary Based on Their Properties: Examining the Impact of Pandemic Awareness with a Hybrid Choice Approach.
Int. J. Environ. Res. Public Health. 20 (2), 1-16, 2023.

Journal metrics:

Q2 Health, Toxicology and Mutagenesis (2022)
Q2 Pollution (2022)
Q2 Public Health, Environmental and Occupational Health (2022)

2021

Wachal, Z., Szilágyi, A., Takács, B., Szabó, A., Priksz, D., Bombicz, M., Szilvássy, J., Juhász, B., Szilvássy, Z., Varga, B.: Improved Survival and Retinal Function of Aging ZDF Rats in Long-Term, Uncontrolled Diabetes by BGP-15 Treatment.
Front. Pharmacol. 12 1-11, 2021.

Journal metrics:

Q1 Pharmacology
Q1 Pharmacology (medical)

2020

Wachal, Z., Bombicz, M., Priksz, D., Hegedűs, C., Kovács, D., Szabó, A., Kiss, R., Németh, J., Juhász, B., Szilvássy, Z., Varga, B.: Retinoprotection by BGP-15, a Hydroximic Acid Derivative, in a Type II Diabetic Rat Model Compared to Glibenclamide, Metformin, and Pioglitazone.
Int. J. Mol. Sci. 21 (6), 1-19, 2020.

Journal metrics:

Q2 Catalysis
D1 Computer Science Applications
D1 Inorganic Chemistry
Q1 Medicine (miscellaneous)
Q2 Molecular Biology
D1 Organic Chemistry
D1 Physical and Theoretical Chemistry
D1 Spectroscopy

2013

Gesztelyi, R., Kiss, Z., Wachal, Z., Juhász, B., Bombicz, M., Csépányi, E., Pák, K., Zsuga, J., Papp, C., Galajda, Z., Branzaniuc, K., Pórszász, R., Szentmiklósi, J., Tósaki, Á.: The surmountable effect of FSCPX, an irreversible A1 adenosine receptor antagonist, on the negative inotropic action of A1 adenosine receptor full agonists in isolated guinea pig left atria.
Arch. Pharm. Res. 36 (3), 293-305, 2013.

Journal metrics:

Q2 Drug Discovery
Q3 Molecular Medicine
Q3 Organic Chemistry

updated: 2024-04-14, 01:34